Barbara Scheiber‐Mojdehkar

Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin

Rayko Evstatiev, Adam Bukaty, Kristine Jimenez et al. · American Journal of Hematology · 2014 · 122 citations · Full text

Medicine, Cell Biology, Hematology +16

An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels

Eppie M. Yiu, Geneieve Tai, Roger E. Peverill et al. · Journal of Neurology · 2015 · 112 citations

Medicine, Neuroscience, Pharmacology +8

Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin

Sylvia Boesch, Brigitte Sturm, Sascha Hering et al. · Annals of Neurology · 2007 · 108 citations

Life Sciences, Pharmacology, Pharmacotherapy +7

Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform

Esther Jacobs, Jan C.M. Hendriks, Berry L.J.H. van Tits et al. · Analytical Biochemistry · 2005 · 102 citations

Medicine, Hematology, Clinical Biochemistry +12

Recombinant human erythropoietin: effects on frataxin expression <i>in vitro</i>

Brigitte Sturm, Daniela Stupphann, Christoph Kaun et al. · European Journal of Clinical Investigation · 2005 · 100 citations · Full text

Life Sciences, Cell Biology, Pathobiology +13